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Evaluation of hepatic functions of the bioartificial liver (BAL) module is essential for
developing an optimal BAL system which can be applied to a patient with fulminant
hepatic failure.  Although hepatic function in BALs has been evaluated only in bio-
chemical activities in previous reports, we assessed a newly designed BAL from a hollow
fiber type not only in biochemical activities such as gluconeogenesis, ureogenesis and
albumin synthesis but also in the expressions of albumin messenger RNA (mRNA) and
cytochrome P450 2B1 mRNA by Northern blot analysis.  One to 3 × 108 hepatocytes
isolated from adult rats were suspended in hydrated collagen, loaded into a hollow
fiber module and perfused with L-15 medium supplemented with various hormones
for 2 to 13 days.  Both production rates of glucose and urea nitrogen were highest on
day 1 (610 µg glucose/107 cells/h and 76.1 µg urea nitrogen/107 cells/h, respectively).
Ureogenesis was maintained for 8 days in BAL, but gluconeogenesis decreased after 7
days.  Albumin production rate increased to day 3, reached its maximum (11.0 µg/107
cells/h) and then gradually decreased.  The expression of albumin mRNA was highest
on day 2 and detectable until day 11.  Cytochrome P450 2B1 mRNA was detected only
on day 2.  Northern blot analysis showed that the maintenance period in each hepatic
function was different.  These results suggested that assessment of the functions at a
molecular level was invaluable in the development of a potential BAL for clinical use.
It might be necessary to reconstruct the lobular system as well as a 3-dimensional
environment for hepatocytes in the BAL to maintain the ability of detoxification such
as cytochrome P450s.
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Despite recent advances in intensive medical
treatment, a patient with fulminant hepatic
failure has a poor prognosis (Pappas, 1988).
Liver transplantation is an effective therapy, but
is not always available.  As another strategy for
the treatment of severe hepatic failure, several
cases using a bioartificial liver (BAL) system
mainly for bridging to a transplant liver have
been reported (Chen et al., 1997).  There are,
however, only a few cases that have recovered
using only a BAL (Matsumura et al., 1987;
Sussman and Kelly, 1993; Chen et al., 1997).  It
is mainly due to the reason why the ability of
BAL as a “biochemical factory” as the liver in
vivo is not completely maintained for a
prolonged period.  Therefore, accurate and
specific assessment of hepatic functions of
bioartificial modules, such as gluconeogenesis,
ureogenesis, albumin synthesis and also ability
of detoxification, is essential for developing an
optimal BAL system.
In previous reports, the hepatic functions of
BALs were evaluated only in the biochemical
activities of glucose, urea nitrogen or albumin
production (Shatford et al., 1992; Takeshita et
al., 1995; Naruse et al., 1996a, 1996b; Sielaff et
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al., 1997) but not on the gene expression level,
although hepatocytes of conventional cultures
are investigated extensively using molecular
methods (Kocarek et al., 1993; Kimball et al.,
1995; Nagaki et al., 1995; Tamura et al., 1995).
In this study, we designed a potential BAL of a
hollow fiber type loading rat hepatocytes at a
high density which maintained hepatic func-
tions.  The medium for perfusion and basement
matrix of a BAL were selected based on results
from hepatocytes cultured on dishes.  Evalua-
tion of maintenance of the liver functions of
BALs over 13 days was performed not only by
biochemical assays but also by Northern blot
analysis of albumin messenger RNA (mRNA)
and cytochrome P450 2B1 (CYP 2B1) mRNA.
Materials and Methods
Reagents
Leibovitz’s L-15 medium (L-15), Williams’ E
medium (WE) and fetal calf serum (FCS) were
obtained from Gibco BRL (Rockville, MD).
Collagenase was from Wako Pure Chemical In-
dustries, Ltd. (Osaka, Japan).  Prolin, insulin,
dexamethasone and glucagon were from Sigma
(St. Louis, MO).  Human epidermal growth
factor (hEGF) was from Wakunaga Pharma-
ceutical Co. (Hiroshima, Japan).  [α-32P]dCTP
was from Amersham (Amersham, United
Kingdom).  Other reagents except described
above were of analytical grade.
Isolation and dish culture of hepatocytes
Hepatocytes were isolated from adult male
Wistar rats (140–170 g) by in situ collagenase
perfusion method modified in our laboratory as
described previously (Kohno et al., 1991).  In
preliminary experiments, to assess maintenance
of the liver-specific functions in a long-term
culture, 2 different types of media and 3 types
of extracellular matrices were examined with
hepatocytes cultured on dishes.  The media
were based on WE or L-15 supplemented with
5% FCS, 5000 KIU/L aprotinin, 10–7 mol/L
insulin, 10–7 mol/L dexamethasone, 10–8 mol/L
glucagon and 10 ng/mL hEGF.  Proline (30 mg/
L) was added only to L-15.  Three types of
matrices tested were non-coated plastic (non-
coated), hydrated collagen gel (collagen gel)
(Enami et al., 1987) and poly-N-p-vinylbenzyl-
D-lactonamide (PVLA) (Akaike et al., 1993).
The culture media were changed every 24 h and
the hepatocytes were cultured for 24 h to 96 h in
a humidified incubator at 37˚C under 5% CO2
in air, and were evaluated by biochemical
assays.
Bioartificial liver module
Hepatocytes were loaded into a hollow fiber
cartridge manufactured for clinical hemodia-
lysis (SULFLUX FS-03, from Kaneka Co.,
Osaka) as a bioartificial liver module.  The car-
tridge had 2 separate chambers:  the space
around the hollow fibers (extracapillary) and
the space within the hollow fibers (lumen).  The
fiber-surface area was 0.3 m2 and volumes of
the lumen and extracapillary space were 35 mL
and 55 mL, respectively.  The device consisted
of polysulfone fibers of a 340 µm inside di-
ameter, a 50 µm membrane thickness and a 0.2
µm porous size.  The extracapillary surfaces of
hollow fibers were precoated with 0.015% type
I collagen solution (cellmatrix, from Nitta
Geratin Co., Osaka) before the inoculation of
hepatocytes.  Isolated hepatocytes with a viabil-
ity more than 80% by trypan blue exclusion test
were suspended in 0.1% type I collagen solu-
tion with concerted L-15 medium (Enami et al.,
1987).  In each experiment, 1.0 to 3.0 × 108
hepatocytes in 40 mL of the collagen gel solu-
tion were loaded into the extracapillary space of
the cartridge.  After 4 h incubation to accelerate
gel formation in a humidified atmosphere of
95% air and 5% CO2 at 37˚C, perfusion of the
luminal space was started with approximately
200 mL of perfusion medium consisting of L-
15 supplemented with 5% FCS, 5000 KIU/L
aprotinin, 30 mg/L prolin, 10–7 mol/L insulin,
10–7 mol/L dexamethasone, 10–8 mol/L glu-
cagon and 10 ng/mL hEGF.  The perfusion
medium was preincubated at 37˚C, given oxy-
gen at 500 mL/min and circulated at approxi-
mately 20 mL/min.  The perfusion medium was
The mRNA expression of hepatocytes in a BAL
105
changed every 24 h and continued to perfuse for
2 to 13 days under a sterilized hood.
Biochemical assay of metabolic activities
Gluconeogenesis
After removal of the perfusion medium, modu-
les were perfused in the luminal space for 2 h
with glucose-free Hanks’ solution (pH 7.4),
supplemented with 10 mmol/L HEPES, 10-5
mol/L glucagon, 2 mmol/L L-alanine, 2 mmol/L
DL-lactic acid.  Glucose in the perfusate was
measured by a Glucose C II-test Wako kit
(Wako) using the mutarotase-glucose oxidase
method (Miwa et al., 1972).
Ureogenesis
After the gluconeogenesis assay, Hanks’ solu-
tion (pH 7.4) with 10 mmol/L HEPES, 5 mmol/
L NH4Cl was perfused in the luminal space for
2 or 3 h.  Urea nitrogen in the perfusate was
measured using a Urea-Nitrogen test kit (Wako)
by the diacetylmonoxime method (Coulombe
and Favreau, 1963).
Albumin assay
After the Hanks’ solution was perfused for
assaying gluconeogenesis and ureogenesis, the
luminal space was perfused with a fresh L-15
medium supplemented with 5% FCS, 5000 KIU/
L aprotinin, 30 mg/L prolin, 10–7 mol/L insulin,
10–7 mol/L dexamethasone, 10–8 mol/L gluca-
gon and 10 ng/mL hEGF for 12 to 25 h.  The albu-
min concentration in the perfusate was mea-
sured by enzyme-linked immunosorbent assay
(ELISA) method (Dunn et al., 1992).  Purified
rat albumin and peroxide-conjugated rabbit
anti-rat albumin antibody was obtained from
ICN Pharmaceuticals (Costa Mesa, CA).  The
antibody was preincubated with an excess of
bovine albumin (30 mg/mL in 0.5% Tween-20
in PBS) before the sample addition in order to
block any cross reaction (Shatford et al., 1992).
Northern blot analysis
Induction of CYP 2B1
To induce CYP 2B1, 1 mmol/L phenobarbital
(Marco Seiyaku Co., Ltd., Nagoya, Japan) was
added to the perfusate for 24 h before the day of
harvesting hepatocytes.
Harvest of hepatocytes
After removing the perfusion medium, the
module was perfused in the extracapillary space
with RNase free 0.05% collagenase solution for
1 h followed by PBS for 1 h to harvest hepato-
cytes.  The collected cell pellets by centrifu-
gation (50 × g, 2 min, 4˚C) were stored at –80˚C
until RNA extraction.
RNA extraction and cDNA probes
Total RNA of hepatocytes was extracted using
an acid guanidinium thiocyanate phenol chloro-
form method (Chomczynski and Sacchi, 1987)
(ISOGEN, from Nippon Gene Co., Ltd., Toyama,
Japan).  The liver RNA was extracted by the
modified guanidine ultracentrifugation method
using Beckman SW41Ti roter (25,000 rpm, 20
h, 20˚C) (Ullrich et al., 1977) from normal liver
specimens and liver specimens of adult Wistar
rats, which were induced CYP 2B1 by intra-
peritoneal injections of phenobarbital at a dose
of 150 mg/kg weight at 48 h and 24 h before
sacrifice.  The rat albumin complementary
DNA (cDNA) probe (HG293: pAct-Alb) was
obtained from the Health Science Research
Resources Bank (Osaka), the rat CYP2B1
cDNA probe (rat pcP-450pb1) (Fujii-Kuriyama
et al., 1982) was from the Riken Gene Bank
(Ibaragi, Japan) and the rat β-actin cDNA probe
was a kind gift from Dr. Ueta (The Gene Re-
search Center, Tottori University).
Northern blot analysis
Total RNA (20 µg) of each sample was hybrid-
ized with [32P]-labeled cDNA probes of rat albu-
min and CYP 2B1.  The same blots were rehybrid-
ized with rat β-actin cDNA probe to assess
equal loading of the blots.  Autoradiograms
were quantified by densitometric scanning
using a Phosphor Image Scanner (Molecular
Imager system GS-525, BioRad, Hercules, CA).
Statistical analysis
Experimental dates were expressed as mean ±
SD (Tables 1 and 2) and mean ± SE (Figs. 1–3).
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The differences between any 2 groups were
analyzed by Mann-Whitney’s U test.  Values of
P < 0.05 were considered significant.
Results
Metabolic activities of hepatocytes
cultured on dishes
Glucose, urea nitrogen and albumin production
rates in hepatocytes cultured on plastic dishes
compared to WE and L-15 medium are sum-
marized in Table 1.  After 24 h in culture, urea
nitrogen production was higher in hepatocytes
cultured with L-15 based medium than the
hepatocytes cultured with WE based medium
(P < 0.05) although gluconeogenesis was high-
er in hepatocytes cultured with WE medium (P
< 0.05).  All production rates, glucose, urea
nitrogen and albumin in hepatocytes cultured
with L-15 were significantly higher than with
WE after 72 h in culture (P < 0.01, P < 0.01, P <
0.001, respectively).  Marked differences in
these activities were observed in hepatocytes
cultured on different types of extracellular
matrices (Table 2).  Production rates of glucose
and urea nitrogen at 48 h (P < 0.001, P < 0.001,
Table 1.  Metabolic activities of hepatocytes cultured on non-coated dishes with WE or L-15
medium for 24 h or 72 h
Medium†           Production rate‡ (µg/107 cells/h)
Glucose Urea nitrogen Albumin
24 h 72 h 24 h 72 h 24 h 72 h
WE 466 ± 30.4 156 ± 9.60   8.40 ± 1.60   6.20 ± 1.60 11.2 ±   5.00   5.30 ± 1.40
L-15 275 ± 22.8 200 ± 8.10 27.8   ± 2.20 15.9   ± 2.60 22.0 ± 11.2 11.0   ± 3.00
P value     0.0103     0.0038   0.0101   0.0039   0.0768   0.0004
FCS, fetal calf serum; hEGF, human epidermal growth factor; L-15, Leibovitz’s L-15 medium; WE,
Williams’ E medium.
† Both media were supplemented with 5% FCS, 5000 KIU/L aprotinin, 10–7 mol/L insulin, 10–7 mol/L
dexamethasone, 10–8 mol/L glucagon and 10 ng/mL hEGF.  the L-15 was added 20 mmol/L NaHCO3 and 30
mg/L proline also.
‡ Production rates were calculated as µg products/107 cells/h and expressed as mean ± SD of 6 dishes in one
experiment.
Mann-Whitney’s U test was performed between WE and L-15 medium.
Table 2.  Metabolic activities of hepatocytes cultured on 3 types of matrix-coated dishes†
Matrix-           Production rate‡ (µg/107 cells/h)
coated Glucose Urea nitrogen Albumin
48 h 96 h 48 h 96 h 48 h 96 h
Non-coated   158 ± 17.1 151 ± 27.5   78.8 ± 25.5  66.2 ± 55.4 21.0 ± 5.10 37.7 ± 21.9
Collagen gel 1780 ± 238*** 914 ± 239***   329  ± 57.5***  245 ± 153* 19.0 ± 6.00NS 53.9 ± 26.9*
PVLA   159 ± 8.70NS 140 ± 22.8NS   66.9 ± 27.0NS   55.4 ±41.0NS 26.9 ± 8.20* 39.5 ± 19.7NS
FCS, fetal calf serum; hEGF, human epidermal growth factor; L-15, Leibovitz’s L-15 medium; PVLA,
poly-N-p-vinylbenzyl-D-lactonamide.
† Hepatocytes were cultured with the L-15 medium supplemented with 20 mmol/L NaHCO3, 5% FCS, 5000
KIU/L aprotinin, 30 mg/L proline, 10–7 mol/L insulin, 10–7 mol/L dexamethasone, 10–8 mol/L glucagon and
10 ng/mL hEGF for 48 h or 96 h.
‡ Production rates were calculated as µg products/107 cells/h and expressed as mean ± SD of 6 dishes in 2
separate experiment.
Mann-Whitney’s U test was performed between non-coated and collagen gel, between non-coated and
PVLA.  *P < 0.05, **P < 0.005, ***P < 0.001; NS, not significant.
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respectively) and all the rates of glucose, urea
nitrogen and albumin at 96 h (P < 0.001, P <
0.05, P < 0.05, respectively) of hepatocytes en-
trapped in collagen gel were significantly high-
er than those of the hepatocytes on non-coated
dishes or on PVLA coated dishes.  According to
these results, L-15 based medium and collagen
gel were selected as the perfusion medium and
the extracellular matrix for a bioartificial liver
module.
Metabolic activities of hepatocytes of
the bioartificial liver module
To evaluate metabolic activities of hepatocytes
in the long-term culture of all modules, the pro-
duction rate was calculated from total cell num-
bers at the time of inoculation and expressed as
µg products/107 cells/h.  The highest glucose
production rate was observed on day 1 (610 µg/
107 cells/h), gradually decreased to 70.2 µg/107
cells/h on day 8 and was maintained until day
10 on the same level (Fig. 1).  The production of
urea nitrogen was highest on day 1 (76.1 µg/107
cells/h) and was maintained to day 8 (32.8 µg/
107 cells/h) as shown in Fig. 2.  Albumin produc-
tion rate was at its maximum on day 3 (11.0 µg/
107 cells/h), then gradually decreased and was
measurable until day 13 in the module (Fig. 3).
Northern blot analysis of hepatocytes of
the bioartificial liver module
The albumin mRNA was expressed in the
hepatocytes cultured in the bioartificial liver
modules from day 2 to day 11 (Fig. 4A).  To
assess quantitative expression of mRNAs, the
ratio of albumin mRNA/β-actin mRNA and
CYP 2B1 mRNA/β-actin mRNA were calcu-
lated (Fig. 5).  It was most strongly expressed
Fig. 1.  Gluconeogenesis of hepatocytes in the bio-
artificial modules.  Production rates were calculated
as µg glucose/107 cells/h and expressed as mean ±
SE of 10 samples in 5 separate experiments.  The
highest glucose production rate was observed on day
1 (610 µg/107 cells/h).
Fig. 2.  Ureogenesis of hepatocytes in the bioartifi-
cial modules.  Production rates were calculated as µg
urea nitrogen/107 cells/h and expressed as mean ±
SE of 10 samples in 5 separate experiments.  The pro-
duction of urea nitrogen was highest on day 1 (76. 1
µg/107 cells/h).
Fig. 3.  Albumin production rate of hepatocytes in
the bioartificial modules.  Production rates were
calculated as µg albumin/107 cells/h and expressed
as mean ± SE of 18 samples in 6 separate experi-
ments.  The albumin production rate was at its maxi-
mum on day 3 (11.0 µg/107 cells/h).
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on day 2 in the ratio of albumin mRNA/β-actin
mRNA and then gradually decreased. The
expression of CYP 2B1 mRNA by induction
with phenobarbital was detected at day 2 but on
very low level (Fig. 4B).  No inducibility of
mRNA of CYP 2B1 was found on day 5 or day
11.  The expression of rat β-actin mRNA, used
as an internal control, was the same level during
culturing in the device (Fig. 4C).
Fig. 4.  Northern blot analysis of hepatocytes in the
bioartificial modules.  A)  Albumin mRNA.  B)
Cytochrome P450 2B1 (CYP 2B1) mRNA.  C) β-
Actin mRNA.  Each lane shows control RNA from a
normal adult rat liver (Normal), RNA from an adult
rat liver induced with phenobarbital (Induced),
RNAs on days 2, 5 and 11 of hepatocytes induced
with phenobarbital from bioartificial liver modules.
Fig. 5.  The ratio of albumin mRNA/β-actin mRNA
expression and cytochrome P450 2B1 (CYP 2B1)
mRNA/β-actin mRNA expression.  Each lane shows
control RNA from a normal adult rat liver (Normal),
RNA from an adult  rat  l iver induced with
phenobarbital (Induced), RNAs on days 2, 5 and 11
of hepatocytes induced with phenobarbital from
bioartificial liver modules.
Discussion
The development of hybrid artificial liver de-
vices has been exhaustively investigated for de-
cades (Matsumura et al., 1987; Takahashi et al.,
1992; Fremond et al., 1993; Li et al., 1993;
Naruse et al., 1996a; Chen et al., 1997), and yet
none of the studies has been established as a
standard clinical treatment for liver failure.  The
complexity of functional activities of the liver
makes it difficult to design such systems.  In
order to develop modules that can support and
improve patients with liver failure, it is neces-
sary to evaluate the functional capacity of
hepatocytes in the systems over periods.  Suit-
able markers for following quantitative specific
functions of the device are required (Lazar et
al., 1995).  We designed a hollow fiber type
BAL inoculating primary hepatocytes from rats
cultured with L-15 medium entrapped in col-
lagen gel which was expected to maintain he-
patic function for a prolonged period.  In addi-
tion to assays of biochemical activities, such as
gluconeogenesis, ureogenesis, and albumin
synthesis, the expression of albumin mRNA
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and CYP 2B1 mRNA by Northern blot analysis
was achieved to clarify whether or not these
functions were present in sufficient amounts.
We selected the L-15 medium as the perfu-
sion medium for the module, but the WE medi-
um had been used in many previous reports
(Shatford et al., 1992; Takeshita et al., 1995;
Naruse et al., 1996a).  The differences between
the L-15 medium and the WE are as follows:
the concentration of amino acids in L-15 is
higher than in WE, galactose is used instead of
glucose in L-15, and the pH of L-15 medium is
stable in an atmosphere without 5% of CO2.
Tanaka and others (1979) reported that hepato-
cytes cultured at a high amino acid concentra-
tion were consuming amino acids and forming a
large amount of urea under an anabolic state.
Although both media contain high concentra-
tions of amino acids, there was a significant dif-
ference in ureogenesis in the experiments of
hepatocytes cultured in dishes.  The stability of
the pH of the medium was also an important
factor in selecting the type of medium, because
the L-15 medium can be recirculated for a long
time without CO2 supplementation.  As well as
the type of medium, the hormonal addition of
10–7 mol/L insulin, 10–7 mol/L dexamethasone,
10–8 mol/L glucagon and 10 ng/mL hEGF was
crucial for the maintenance of hepatic functions
(data not shown).  The levels of biochemical
activities in BAL were found to be lower than
those in the dish-cultures.  It could be because
the amounts of the perfusion medium were not
sufficient and hepatocytes in BAL could not
exert full hepatic functions.  Culturing hepato-
cytes in an atomosphere without CO2 might be
another cause of low hepatic functions of
BALs.  Further studies are needed on these as-
pects.
It was also important to choose an appro-
priate basement matrix for hepatocytes in the
hollow fiber module.  The data of hepatocytes
cultured on dishes showed marked differences
in the production rates of glucose, urea nitrogen
and albumin between the collagen gel and non-
coated dishes.  Many investigations on the ef-
fects of the extracellular matrix revealed that
the constituents of the extracellular matrix for
hepatocytes in vitro strongly influence expres-
sion and maintenance of liver specific genes
(Kocarek et al., 1993; Nagaki et al., 1995; Tamura
et al., 1995).  Two different types of matrices,
collagen gel and PVLA, both providing a 3-
dimensional configuration for hepatocytes,
were studied (Akaike et al., 1993; Lazar et al.,
1995).  Hepatocytes entrapped in collagen gel
were found maintaining much higher levels of
biochemical activities consistant with several
reports of BAL systems using collagen gel as a
cellular matrix in the hollow fiber cartridge
(Shatford et al., 1992; Sielaff et al., 1995a;
Takeshita et al., 1995).  To obtain a firm attach-
ment of hepatocytes in the extracapillary mem-
brane of fibers, we modified the method of
hepatocyte inoculation; firstly, we coated the
extracapillary membrane with a low concen-
tration (0.015%) of collagen solution, then
loaded the hepatocytes in 0.1% hydrated col-
lagen and then incubated them at 37˚C allowing
them to gel rapidly to avoid a disproportional
distribution of collagen gel in the extracapillary
space.
Determination of albumin production in
perfusates has been supposed to be an optimal
index of the metabolic activities of hepatocytes
because albumin is stable in media and only
hepatocytes synthesize it (Rothschild et al.,
1972).  But the biochemical assay of albumin in
perfusates does not completely reflect the new-
ly synthesized albumin.  Even if the perfusion
medium was changed every day and there were
be no stored albumin in the medium being used
in our experiments, the albumin stored in the
extracapillary space of the hollow-fiber module
could not be neglected.  Thus, we performed an
albumin mRNA analysis in addition to a bio-
chemical assay by ELISA.  Northern blot
analysis reflects the transcriptional activity of
the albumin gene at the time of cell harvest so
that the existence of stored albumin in the
extracapillary space or cross-reaction to FCS in
the medium can be neglected.  There are no pre-
vious reports evaluating the functional activity
of BALs in mRNA levels, mainly because
hepatocytes must be collected from devices,
which means the end of perfusion experiments.
The albumin mRNA in our module was main-
tained for 11 days.  The change of expression
S. Okada et al.
110
levels of mRNA (Fig. 4) was parallel to the
change of albumin production rates measured
by ELISA in the media (Fig. 3).  This result sug-
gests that the measurement of albumin produc-
tion in perfusates correctly reflects the newly
synthesized albumin in hepatocytes of a BAL.
We also performed Northern blot analysis of
CYP 2B1 mRNA as an index of the ability of
detoxification of the module.  In previous re-
ports, the drug metabolizing activity of a BAL
was assessed by measuring concentrations of
certain drugs, for example lidocaine, and their
metabolites by high performance liquid chro-
matography (Shatford et al., 1992; Nyberg et
al., 1993; Rozga et al., 1993).  The increased
concentration of metabolites shows the activity
of cytochrome P450 related drug enzymes and a
part of the drug metabolic pathway, but does
not show general levels or the inducibility of
cytochrome P450s.  It was, therefore, thought to
be valuable to perform Northern blot analysis.
In the present study, the inducibility and
expression of CYP 2B1 mRNA was maintained
for a shorter term than the expression of
albumin mRNA.  Although albumin synthesis
might be a useful marker of hepatocyte viability
(Sielaff et al., 1995b), in the sense of potential
therapeutic value for patients with liver failure,
cytochrome P450 activity is suggested to be the
critical function that must be provided by suc-
cessful liver assistance devices (Nyberg et al.,
1993).  A number of researchers (Kocarek et al.,
1993; Sidhu et al., 1993; Donato et al., 1994)
have demonstrated that hepatocytes in culture
expressed constitutive cytochrome P450 activi-
ty only in a differentiated environment.  It is
known that their distribution of the expression
of cytochrome P450s in the hepatocytes in vivo
depends on the location of the hepatocytes in
the lobules, for example Zones 1, 2 and 3
(Wojcik et al., 1988).  In order to maintain high
levels of the expression of cytochrome P450s,
the reconstruction of the lobular system in the
BAL seemed necessary.  Hepatocytes in this
study were entrapped in collagen gel and loaded
into the device evenly so that hepatocytes
should have been under a 3-dimensional config-
uration (Lazar et al., 1995).  Even under these
conditions, hepatocytes maintained CYP 2B1
mRNA only for 2 days in the BAL, which is not
a completely suitable environment for hepato-
cytes.  It is necessary for hepatocytes to have
proper polarity and microcirculation likely in
vivo, including the presence of vessels, non-
parenchymal cells and bile duct systems.
In summary, we evaluated the maintenance
of hepatic functions of a potential hollow fiber
type BAL by biochemical activities and mRNA
levels.  The albumin mRNA was detected for 11
days parallel to albumin production measured
by ELISA.  The expression of CYP 2B1
mRNA, however, was maintained only for a
short term even though it was expected to main-
tain itself for as long a period as albumin.  It
should be necessary to reconstitute a micro-
environment for hepatocytes in a BAL as in
vivo, probably retaining zone lobulation, to
achieve the total functions of the liver.
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